Of cells for treatment for sickle cell anemia ExamineResearchers at the Boston University School of Medicine have recently been a five-year awarded $ 9,000 grant from the National Heart, and Blood Institute , the mass-produced produce sickle cell disease – specific induced pluripotent stem cells . Under the direction of Principal Investigator Martin H viagra vs levitra . Steinberg, MD , and George Murphy, the researchers propose making iPS cells from the blood of patients with sickle cell disease, to certain genes certain genes involved in the disease.

A novel excise reprogramming vector, they produce clinical grade ‘ human iPS cells from free – radical reprogramming transgenes. This iPS cells directly differentiated sickle used to understand an unlimited supply of erythroid-lineage cells better HbF gene regulation and conduct preclinical small molecule drug screens to produce. – Lights These act like behave like certain genes in different tissues , and should the mechanisms by which a gene with a disease affects biology biology of various tissues, said Susan B. Deputy Director of the National Institutes of Health , NHLBI, Is is most studies. Is The understanding of the cellular and tissue biology allow us to develop and test new therapies and methods of prevention. These approaches with iPS cells on a large scale could improve the predictive value of preclinical testing, benefit regenerative medicine and reduce the need for animal models of disease .

click here

####This work was supported by a grant from of the NIH.

Other articles from "clinical":

Random articles